aztreonam and Nausea
aztreonam has been researched along with Nausea in 2 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tigecycline monotherapy is a safe and effective therapy for cSSSIs in geographically distinct populations in Asia." | 2.76 | Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan. ( Aradhya, S; Chang, CM; Chuang, YC; Cooper, A; Dartois, N; Jouve, S; Nagari, B; Pai, V, 2011) |
| " Safety was assessed by physical examination, laboratory analyses, and adverse event reporting." | 2.71 | Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial. ( Campos, ME; Curcio, D; Ellis-Grosse, E; Embil, JM; Loh, E; Penn, RL; Rose, G; Sacchidanand, S, 2005) |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chuang, YC | 1 |
| Chang, CM | 1 |
| Aradhya, S | 1 |
| Nagari, B | 1 |
| Pai, V | 1 |
| Dartois, N | 1 |
| Jouve, S | 1 |
| Cooper, A | 1 |
| Sacchidanand, S | 1 |
| Penn, RL | 1 |
| Embil, JM | 1 |
| Campos, ME | 1 |
| Curcio, D | 1 |
| Ellis-Grosse, E | 1 |
| Loh, E | 1 |
| Rose, G | 1 |
Trials
2 trials available for aztreonam and Nausea
| Article | Year |
|---|---|
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Double-Blind Method; Drug Therapy, Combination; Femal | 2011 |
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
Topics: Anti-Bacterial Agents; Aztreonam; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Posit | 2005 |